Hot Life Science Investor Mandate 3: Asian Pharma Company Seeks Oncology Assets

1 Oct

A biopharmaceutical company based in Asia seeks research collaboration, in-licensing, and partnering opportunities with companies mainly in the oncology space. The firm seeks 3-5 projects within the next year. The firm has a “no research, development only” model, and licenses drug candidates ranging from preclinical to clinical stages. The firm currently has projects from the USA and Europe, though is open to projects globally.

The pharma firm seeks biotech therapeutics in oncology and Asian prevalent diseases, such as hepatoma (liver cancer), soft tissue sarcoma, as well as other local diseases in Asia. The firm will consider therapeutics in all phases, and has a particular interest in small biotech companies.

The firm prefers a management team with experience in oncology and other relevant fields of science. As a public company, the firm will partner with the company and collaborate with its research and development.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: